PRIMO BRANDS CORP

Insider Trading & Executive Data

PRMB
NYSE
Consumer Defensive
Beverages - Non-Alcoholic

Start Free Trial

Get the full insider signal for PRMB

49 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
49
0 in last 30 days
Buy / Sell (1Y)
34/15
Acquisitions / Dispositions
Unique Insiders (1Y)
17
Active in past year
Insider Positions
23
Current holdings
Position Status
20/3
Active / Exited
Institutional Holders
346
Latest quarter
Board Members
18

Compensation & Governance

Avg Total Compensation
$9.7M
Latest year: 2024
Executives Covered
5
Comp records available
Form 8-K Events (1Y)
6
Personnel Changes (1Y)
6
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
4
Board Appointments (1Y)
4
Board Departures (1Y)
4

Restricted Sales

Form 144 Filings (1Y)
1
Form 144 Insiders (1Y)
1
Planned Sale Shares (1Y)
18.6M
Planned Sale Value (1Y)
$295.1M
Price
$22.55
Market Cap
$8.3B
Volume
42,962
EPS
$0.16
Revenue
$6.7B
Employees
13.7K
About PRIMO BRANDS CORP

Company Overview

Primo Brands is a North American branded beverage company formed by the combination of Primo Water and BlueTriton, selling spring, purified, sparkling and flavored/enhanced waters plus dispensers and filtration/coffee services across the U.S. and Canada. The business is vertically integrated with >70 production facilities, ~240 depots, a ~5,900 vehicle delivery fleet, large DTC operations (Water Direct/Exchange/Refill) and a portfolio that includes billion‑dollar and regional brands such as Poland Spring and Pure Life. The company is volume- and recurring‑revenue driven, recently grew net sales materially from the transaction, is pursuing $300M of transaction synergies, and operates with high leverage (~$5.0B debt) and concentrated customer exposure (~24% of 2024 sales).

Executive Compensation Practices

Given Primo’s recent transformational acquisition and integration focus, compensation for senior executives is likely weighted toward performance metrics tied to adjusted EBITDA, synergies realization, organic volume growth (DTC retention and subscriptions), gross margin expansion and free cash flow/working capital improvement that support debt servicing. Short‑term incentive pay will plausibly emphasize quarterly/annual sales and integration milestones, while long‑term incentives are probably equity‑based (RSUs, performance shares and retention awards) that vest on multi‑year EBITDA, synergy and total shareholder return targets—including specific retention grants tied to the Transaction and merger-related milestones. Compensation committees will also need to account for high leverage and refinancing risk (covenant outcomes), commodity input volatility (PET/resin/fuel) and regulatory/sustainability goals (circular packaging, water source stewardship), so non‑financial KPIs (ESG, safety, quality/compliance) may factor into pay and discretionary adjustments. Finally, the company’s recent share repurchases and dividends indicate management is balancing cash returns with debt reduction, which can influence realized pay for executives with equity holdings.

Insider Trading Considerations

Material non‑public information at Primo is likely to revolve around integration progress, synergy timing/amounts, refinancing/covenant developments, major customer contract changes, seasonal demand swings (summer peak), and commodity cost pass‑through decisions—each could materially move the stock and therefore merit strict trading windows and preclearance. The post‑transaction period commonly produces retention vesting schedules and one‑time equity awards, so expect clustered insider sales after vesting/lockup expirations and possible opportunistic buys or buys by insiders to signal confidence during refinancing steps or large buyback programs. Regulatory constraints are amplified by the industry’s heavy FDA/EPA/state oversight and state container deposit regimes, and insiders should avoid trading on confidential supply/recall or regulatory disclosure items; use of 10b5‑1 plans, blackout windows around earnings and pre‑clearance procedures are prudent and likely in place.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for PRIMO BRANDS CORP and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime